AtriCure Settles Medicare Fraud Claims For $3.8M

By Jacqueline Bell

Law360, New York (February 03, 2010, 5:50 PM ET) -- Medical device maker AtriCure Inc. has reached a $3.76 million settlement with the U.S. Department of Justice, putting to rest claims that the company improperly marketed devices used to treat abnormal heart rhythms and enticed physicians and hospitals to inflate Medicare costs related to their use.

The agreement resolves allegations raised in a DOJ investigation and a related whistleblower case in the U.S. District Court for the Southern District of Texas that AtriCure marketed its surgical ablation systems used to treat atrial fibrillation, a common type...
To view the full article, take a free trial now.

Already a subscriber? Click here to login

You must correct or enter the following before you can submit this form:

All fields required

  5. Required

Only Law360 gives you:

Non-stop coverage of high-stakes litigation across 30 practices

Real-time tracking and reports on 10,000+ companies, firms and industries

Over 80,000 attorney profiles with neutral data collected from active lawsuits

Research tools to find cases, court documents, attorneys and companies

Customized feeds and alerts that can easily be shared with colleagues

In-depth expert analysis from high-profile attorneys at top firms

Access to our vault with over 75,000 original articles